Dengue Fever
📧 Sign up to get email alerts when something new happens for Dengue Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects [Phase 2]
Phase 2 trial update for a tetravalent dengue vaccine (ChimeriVax) in healthy subjects; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule [Phase 2]
Phase 2 trial update evaluating immunogenicity and safety of a tetravalent dengue vaccine booster in adults who completed a 3-dose schedule;…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule [Phase 2]
Phase 2 trial update on a booster dose of a tetravalent dengue vaccine in individuals who completed the 3-dose schedule; results have been p…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine [Phase 2]
Phase 2 trial evaluating immune response to different schedules of a tetravalent dengue vaccine given with or without yellow fever vaccine; …
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US [Phase 2]
A Phase 2 clinical trial evaluated immunogenicity and safety of three dengue vaccine formulations in healthy adults aged 18-45 in the US; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America [Phase 3]
Phase 3 trial of a novel tetravalent dengue vaccine in children and adolescents completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of a two-dose tetravalent dengue virus purified inactivated vaccine vs placebo in healthy…
-
EMA approval · 2018-10-19First vaccine for prevention of dengue
The European Medicines Agency announced the first vaccine approved for dengue prevention.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Sensitivity Study of Diagnostic for Early Detection of Dengue Infection
A completed sensitivity study evaluating an early-detection diagnostic test for Dengue infection, sponsored by InBios International.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years [Phase 2]
Phase 2 trial assessing safety and immunogenicity of a tetravalent chimeric dengue vaccine in healthy volunteers aged 1.5 to 45 years has co…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Specificity Study of Diagnostic for Early Detection of Dengue Infection
This completed clinical trial from InBios International evaluated the specificity of a diagnostic test for early detection of dengue infecti…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children [Phase 2]
Phase 2 study evaluating two doses of the WRAIR Dengue Vaccine given six months apart in healthy adults and children completed. Results were…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) [Phase 1]
A Phase 1 trial evaluating the safety and immunogenicity of a two-dose tetravalent dengue virus purified-inactivated vaccine versus placebo …
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Pilot Survey of Dengue Fever in Solomon Islands
This entry covers a completed pilot survey of dengue fever in the Solomon Islands, sponsored by Kaohsiung Medical University Chung-Ho Memori…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever [Phase 1]
Phase 1 safety and immunogenicity study of TDV, a live attenuated tetravalent dengue vaccine, completed with results posted.
-
CLINICAL_TRIALS research · 2017-02-02Clinical Trial Update: Factors Associated With Poor Dengue Outcomes in Malaysia
A completed clinical trial from Malaysia examining factors associated with poor outcomes in dengue fever.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity [Phase 1]
Phase 1 trial comparing subcutaneous vs intramuscular administration of DENVax (TDV) focusing on safety and immunogenicity in dengue fever.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America [Phase 2]
Phase 2 trial update on immunogenicity and safety of Sanofi Pasteur's CYD Dengue vaccine in healthy children and adolescents in Latin Americ…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease [Phase 1]
Phase 1 trial evaluating the safety and potential protection against dengue fever using a DNA vaccine; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India [Phase 2]
Phase 2 trial update of a tetravalent dengue vaccine in healthy adults in India; study completed with results posted.
-
CLINICAL_TRIALS other · 2016-10-11Clinical Trial Update: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
A clinical trial update notes that the NCT01550016 dengue risk assessment study sponsored by University of Heidelberg Medical Center has com…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Laboratory Diagnosis and Prognosis of Severe Dengue
This clinical trial update covers laboratory diagnosis and prognosis of severe dengue. The study conducted by the Oxford University Clinical…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) [Phase 2]
Phase 2 clinical trial update evaluating safety and immunogenicity of three formulations of Takeda's tetravalent dengue vaccine candidate (T…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Ketotifen as a Treatment for Vascular Leakage During Dengue Fever [Phase 4]
Phase 4 clinical trial evaluating ketotifen to reduce vascular leakage in dengue fever. The trial status is currently unknown.
-
CLINICAL_TRIALS research · 2016-02-01Clinical Trial Update: The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia
This completed study investigates the clinical epidemiology of hospitalized dengue cases in Malaysia.